Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.89 |
| ▸ | LMNA | P02545 | 4/20 | 0.89 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.89 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.45 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9069191 | 1.00 | ALDH1A1 (0.89) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| SCHEMBL823027 | 0.96 | ALDH1A1 (0.81) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| Octocrylene SCHEMBL16483 | 0.94 | ALDH1A1 (1.00) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| Octocrylene SCHEMBL1769135 | 0.94 | ALDH1A1 (1.00) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| Octocrylene SCHEMBL818975 | 0.94 | ALDH1A1 (0.93) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| Octocrylene SCHEMBL28123035 | 0.93 | ALDH1A1 (0.98) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| SCHEMBL445181 | 0.93 | ALDH1A1 (0.77) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| Octocrylene SCHEMBL19583477 | 0.92 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| SCHEMBL9069193 | 0.92 | ALDH1A1 (0.89) | ALDH1A1LMNAMAPK1CYP3A4CA2 | |
| SCHEMBL16806267 | 0.92 | ALDH1A1 (0.89) | ALDH1A1LMNAMAPK1CYP3A4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140134118-A1 | SUNSCREEN COMPOSITION | CONOPCO, INC., D/B/A UNILEVER | 2014-05-15 | — | — | US | disclosed |
| US-8431112-B2 | Photostabilization of cholecalciferol with alkoxycrylene compounds | Hallstar Innocations Corp. (US) | 2013-04-30 | — | — | US | disclosed |
| US-8329148-B1 | Photostabilization of coenzyme Q compounds with alkoxycrylene compounds | HALLSTAR INNOVATIONS CORP. (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120308495-A1 | PHOTOSTABILIZATION OF COENZYME Q COMPOUNDS WITH ALKOXYCRYLENE COMPOUNDS | HALLSTAR INNOVATION CORP. (US) | 2012-12-06 | — | — | US | disclosed |
| US-8278332-B2 | Photostabilization of retinoids with alkoxycrylene compounds | HALLSTAR INNOVATIONS CORP. (US) | 2012-10-02 | — | — | US | disclosed |
| US-8268294-B2 | Photostabilization of retinoids with alkoxycrylene compounds | HALLSTAR INNOVATIONS CORP. (US) | 2012-09-18 | — | — | US | disclosed |
| US-8263051-B2 | Photostabilization of resveratrol with alkoxycrylene compounds | HALLSTAR INNOVATIONS CORP. (US) | 2012-09-11 | — | — | US | disclosed |
| US-8257687-B2 | Photostabilization of coenzyme Q compounds with alkoxycrylene compounds | HALLSTAR INNOVATIONS CORP. (US) | 2012-09-04 | — | — | US | disclosed |
| US-20120114572-A1 | Photostabilization of coenzyme Q compounds with alkoxycrylene compounds | HALLSTAR INNOVATIONS CORP. (US) | 2012-05-10 | — | — | US | disclosed |
| US-20120107255-A1 | PHOTOSTABILIZATION OF CHOLECALCIFEROL WITH ALKOXYCRYLENE COMPOUNDS | HALLSTAR INNOVATIONS CORP. (US) | 2012-05-03 | — | — | US | disclosed |
| US-20120065232-A1 | PHOTOSTABILIZATION OF RETINOIDS WITH ALKOXYCRYLENE COMPOUNDS | HALLSTAR INNOVATIONS CORP. (US) | 2012-03-15 | — | — | US | disclosed |
| US-20110251242-A1 | PHOTOSTABILIZATION OF RESVERATROL WITH ALKOXYCRYLENE COMPOUNDS | HALLSTAR INNOVATIONS CORP. (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110142771-A1 | Photostabilization of Retinoids with Alkoxycrylene Compounds | HALLSTAR INNOVATIONS CORP. (US) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140134118-A1 | SUNSCREEN COMPOSITION | ERCC4, ERCC5, ERCC1 | ALDH1A1 425/4885LMNA 1702/4885MAPK1 4514/4885 |
| US-20110142771-A1 | Photostabilization of Retinoids with Alkoxycrylene Compounds | RBP4, RARA, RBP1 | ALDH1A1 60/4885LMNA 408/4885MAPK1 1181/4885 |
| US-20120308495-A1 | PHOTOSTABILIZATION OF COENZYME Q COMPOUNDS WITH ALKOXYCRYLENE COMPOUNDS | NDUFA10, COQ8A, NDUFB10 | ALDH1A1 237/4885LMNA 474/4885MAPK1 3240/4885 |
| US-20120107255-A1 | PHOTOSTABILIZATION OF CHOLECALCIFEROL WITH ALKOXYCRYLENE COMPOUNDS | CYP2R1, VDR, CYP24A1 | ALDH1A1 228/4885LMNA 337/4885MAPK1 2279/4885 |
| US-20120065232-A1 | PHOTOSTABILIZATION OF RETINOIDS WITH ALKOXYCRYLENE COMPOUNDS | RBP4, RARA, RBP1 | ALDH1A1 57/4885LMNA 495/4885MAPK1 1332/4885 |
| US-20120114572-A1 | Photostabilization of coenzyme Q compounds with alkoxycrylene compounds | NDUFA10, COQ8A, NDUFB10 | ALDH1A1 237/4885LMNA 474/4885MAPK1 3240/4885 |
| US-20110251242-A1 | PHOTOSTABILIZATION OF RESVERATROL WITH ALKOXYCRYLENE COMPOUNDS | CBR1, CBR3, PC | ALDH1A1 223/4885LMNA 636/4885MAPK1 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.